勘误：亚氯酸钠保存的0.1%酒石酸溴莫尼定对日本正在接受治疗的正常眼压性青光眼患者的疗效和安全性[勘误]
Erratum: The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients [Corrigendum].
出版信息
Clin Ophthalmol. 2015 Mar 9;9:453. doi: 10.2147/OPTH.S81448. eCollection 2015.
Abstract
[This corrects the article on p. 1681 in vol. 8, PMID: 25214761.].
摘要
[这纠正了第8卷第1681页上的文章， PMID: 25214761。]
相似文献
1
Erratum: The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients [Corrigendum].勘误：亚氯酸钠保存的0.1%酒石酸溴莫尼定对日本正在接受治疗的正常眼压性青光眼患者的疗效和安全性[勘误]
Clin Ophthalmol. 2015 Mar 9;9:453. doi: 10.2147/OPTH.S81448. eCollection 2015.
2
Erratum: The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients [Corrigendum].勘误：亚氯酸钠保存的0.1%酒石酸溴莫尼定对日本正在接受治疗的正常眼压性青光眼患者的疗效和安全性[勘误]
Clin Ophthalmol. 2015 Jul 22;9:1365. doi: 10.2147/OPTH.S91388. eCollection 2015.
3
The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients.在接受治疗的日本正常眼压性青光眼患者中，添加用亚氯酸钠保存的0.1%酒石酸溴莫尼定的疗效和安全性。
Clin Ophthalmol. 2014 Sep 1;8:1681-7. doi: 10.2147/OPTH.S67366. eCollection 2014.
4
Multicenter, Randomized, Investigator-Masked Study Comparing Brimonidine Tartrate 0.1% and Timolol Maleate 0.5% as Adjunctive Therapies to Prostaglandin Analogues in Normal-Tension Glaucoma.多中心、随机、研究者设盲研究：比较0.1%酒石酸溴莫尼定与0.5%马来酸噻吗洛尔作为正常眼压性青光眼辅助治疗药物与前列腺素类似物的疗效
Adv Ther. 2017 Jun;34(6):1438-1448. doi: 10.1007/s12325-017-0552-5. Epub 2017 May 15.
5
The safety and intraocular pressure-lowering efficacy of brimonidine tartrate 0.15% preserved with polyquaternium-1.用聚季铵盐-1保存的0.15%酒石酸溴莫尼定的安全性和降眼压疗效。
Ophthalmology. 2006 Aug;113(8):1333-9. doi: 10.1016/j.ophtha.2006.03.025.
6
Corrigendum.勘误
Paediatr Child Health. 2015 Nov-Dec;20(8):466-7. doi: 10.1093/pch/20.8.466.
7
Erratum: Efficacy and safety of indacaterol/glycopyrronium in Japanese patients with COPD: a subgroup analysis from the SHINE study [Corrigendum].勘误：茚达特罗/格隆溴铵在日本慢性阻塞性肺疾病患者中的疗效和安全性：SHINE研究的亚组分析[勘误]
Int J Chron Obstruct Pulmon Dis. 2017 Jan 10;12:231. doi: 10.2147/COPD.S127610. eCollection 2017.
8
Brimonidine tartrate for the treatment of glaucoma.酒石酸溴莫尼定治疗青光眼。
Expert Opin Pharmacother. 2019 Jan;20(1):115-122. doi: 10.1080/14656566.2018.1544241. Epub 2018 Nov 8.
9
Erratum: Assessment of safety and efficacy of lamotrigine over the course of 1-year observation in Japanese patients with bipolar disorder: post-marketing surveillance study report [Corrigendum].勘误：拉莫三嗪在日本双相情感障碍患者1年观察期内的安全性和有效性评估：上市后监测研究报告[更正]
Neuropsychiatr Dis Treat. 2017 Aug 18;13:2219. doi: 10.2147/NDT.S148233. eCollection 2017.
10
Twelve-month results of an ongoing randomized trial comparing brimonidine tartrate 0.2% and timolol 0.5% given twice daily in patients with glaucoma or ocular hypertension. Brimonidine Study Group 2.一项正在进行的随机试验的12个月结果，该试验比较了0.2%酒石酸溴莫尼定和0.5%噻吗洛尔每日两次给药于青光眼或高眼压症患者的疗效。溴莫尼定研究组2。
Ophthalmology. 1998 Oct;105(10):1960-7. doi: 10.1016/s0161-6420(98)91048-x.
Zotero 插件